IPHA
Price
$1.79
Change
-$0.12 (-6.28%)
Updated
Apr 2 closing price
Capitalization
167.19M
40 days until earnings call
MDGL
Price
$334.60
Change
+$10.62 (+3.28%)
Updated
Apr 2 closing price
Capitalization
7.39B
40 days until earnings call
Ad is loading...

IPHA vs MDGL

Header iconIPHA vs MDGL Comparison
Open Charts IPHA vs MDGLBanner chart's image
Innate Pharma SA
Price$1.79
Change-$0.12 (-6.28%)
Volume$116.11K
Capitalization167.19M
Madrigal Pharmaceuticals
Price$334.60
Change+$10.62 (+3.28%)
Volume$365.42K
Capitalization7.39B
IPHA vs MDGL Comparison Chart
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. MDGL commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a Hold and MDGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (IPHA: $1.91 vs. MDGL: $334.60)
Brand notoriety: IPHA and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 4% vs. MDGL: 71%
Market capitalization -- IPHA: $167.19M vs. MDGL: $7.39B
IPHA [@Biotechnology] is valued at $167.19M. MDGL’s [@Biotechnology] market capitalization is $7.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • IPHA’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 3 TA indicator(s) are bullish while MDGL’s TA Score has 3 bullish TA indicator(s).

  • IPHA’s TA Score: 3 bullish, 7 bearish.
  • MDGL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than IPHA.

Price Growth

IPHA (@Biotechnology) experienced а -3.05% price change this week, while MDGL (@Biotechnology) price change was +0.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

IPHA is expected to report earnings on May 13, 2025.

MDGL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($7.39B) has a higher market cap than IPHA($167M). MDGL YTD gains are higher at: 8.436 vs. IPHA (-2.717).
IPHAMDGLIPHA / MDGL
Capitalization167M7.39B2%
EBITDAN/A-450.12M-
Gain YTD-2.7178.436-32%
P/E RatioN/AN/A-
RevenueN/A180M-
Total CashN/A926M-
Total DebtN/A120M-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
28
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHAMDGL
RSI
ODDS (%)
Bearish Trend 7 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
72%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 23 days ago
84%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 7 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSLV11.600.08
+0.69%
Sprott Physical Silver Trust
BRF12.990.04
+0.33%
VanEck Brazil Small-Cap ETF
IGTR24.480.05
+0.20%
Innovator Gradient Tactical Rot Str ETF
NCZ11.770.02
+0.17%
Virtus Convertible & Income Fund II
PCN13.64N/A
N/A
PIMCO Corporate & Income Strategy Fund

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
-6.28%
MDGL - IPHA
43%
Loosely correlated
+3.28%
SLNO - IPHA
34%
Loosely correlated
+7.93%
VALN - IPHA
30%
Poorly correlated
+2.36%
LRMR - IPHA
29%
Poorly correlated
+10.00%
QSI - IPHA
28%
Poorly correlated
+2.50%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KANT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+3.28%
KANT - MDGL
62%
Loosely correlated
+7.22%
ALXO - MDGL
56%
Loosely correlated
-2.70%
ZNTL - MDGL
51%
Loosely correlated
-2.52%
CGEM - MDGL
50%
Loosely correlated
+4.27%
TSVT - MDGL
50%
Loosely correlated
+0.20%
More